Schering adds DrKW for defence

Schering, the German pharmaceuticals group fighting off a €14.6bn ($17.4bn) hostile bid from local rival Merck, has added Dresdner Kleinwort Wasserstein to its defence team. Morgan Stanley is already advising.

A spokeswoman for DrKW confirmed the appointment.

WSJ Logo
Pro Bono or Pro Nono? Law Firms Split on Fulfilling Deals With TrumpExternal link

Pro Bono or Pro Nono? Law Firms Split on Fulfilling Deals With Trump